United Therapeutics (UTHR) has a strong earnings-surprise history and currently shows the two key ingredients that make a near-term earnings beat likely. This increases the probability of an above-consensus print that could move the stock modestly (roughly 1–3%) on the report, implying near-term upside risk for holders and traders.
United Therapeutics (UTHR) has a strong earnings-surprise history and currently shows the two key ingredients that make a near-term earnings beat likely. This increases the probability of an above-consensus print that could move the stock modestly (roughly 1–3%) on the report, implying near-term upside risk for holders and traders.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.30
Ticker Sentiment
